Europe — EMA
Lenalidomid Grindeks
GNH USA supplies Lenalidomid Grindeks (Lenalidomide), a immunomodulatory imide drug for multiple myeloma and del(5q) myelodysplastic syndromes.
Request sourcing
What is Lenalidomide?
Lenalidomide, the active ingredient in Lenalidomid Grindeks, is a immunomodulatory imide drug (IMiD) presented as a tablet for oral use. It treats multiple myeloma and myelodysplastic syndromes with del(5q) in adult patients.
GNH USA supplies Lenalidomid Grindeks as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres and pharmacies worldwide.
What is Lenalidomide used for?
Lenalidomid Grindeks is an immunomodulatory agent used in specific hematologic malignancies.
Multiple Myeloma: improves disease control and prolongs progression‑free survival. Myelodysplastic Syndromes with del(5q): reduces transfusion dependence and improves hematologic parameters.
What are the side effects of Lenalidomide?
Lenalidomid Grindeks may cause a range of adverse reactions.
Common Side Effects: - Fatigue: persistent tiredness reported by many patients. - Neutropenia: reduced neutrophil count increasing infection risk. - Thrombocytopenia: lowered platelet levels leading to bruising. - Anemia: decreased red blood cell count causing weakness. - Diarrhea: loose stools of varying severity. - Rash: mild skin irritation or erythema.
Serious or Rare Side Effects: - Venous thromboembolism: blood clots in deep veins or lungs. - Severe neutropenia: profound immune suppression requiring medical attention. - Secondary primary malignancies: emergence of new cancers. - Hepatic failure: significant liver enzyme elevations or dysfunction. - Stevens‑Johnson syndrome: severe skin reaction with blistering.
What precautions apply to Lenalidomide?
Before initiating therapy, clinicians should evaluate several safety considerations.
Monitor blood counts: perform regular CBC to detect cytopenias. Assess thrombotic risk: consider prophylactic anticoagulation when risk is high. Evaluate organ function: check renal and hepatic parameters periodically. Avoid in pregnancy: teratogenic potential requires strict contraception. Use contraception: both male and female patients must employ effective methods. Store below 25°C: keep in the original pack, protect from moisture.
What does Lenalidomide interact with?
Lenalidomid Grindeks can interact with other medicines, requiring careful management.
Major Interactions (Avoid): - Strong CYP3A4 inhibitors: may increase lenalidomide exposure. - Thalidomide: combined use heightens teratogenic risk. - Anticoagulants: concurrent use can raise clotting complications.
Moderate Interactions (Monitor Closely): - CYP3A4 inducers: may reduce therapeutic levels. - NSAIDs: increase risk of gastrointestinal bleeding.
Frequently asked questions
What conditions is Lenalidomid Grindeks used for?+
How does lenalidomide work in the body?+
What is the usual dose of Lenalidomid Grindeks?+
Is Lenalidomid Grindeks safe during pregnancy or breastfeeding?+
How do I order Lenalidomid Grindeks from GNH USA?+
How does Lenalidomid Grindeks compare with other treatments for multiple myeloma?+
What are the recommended storage conditions for Lenalidomid Grindeks?+
How is Lenalidomid Grindeks administered?+
What are the most serious risks associated with Lenalidomid Grindeks?+
Who should not use Lenalidomid Grindeks?+
Product details
Related products

A
Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

A
Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

A
Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

A
Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo